CD101 Antibody, anti-human, Vio® Bright FITC 130-104-728 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD101 Antibody, anti-human, Vio® Bright FITC

The CD101 Antibody, anti-human, Vio® Bright FITC from Miltenyi Biotec is a Mouse Monoclonal antibody to CD101. This antibody recognizes Human antigen. The CD101 Antibody, anti-human, Vio® Bright FITC has been validated for the following applications: Flow Cytometry.

Product Specs
ItemCD101 Antibody, anti-human, Vio® Bright FITC
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-104-728
Quantity100 tests in 1 mL
ApplicationsFlow cytometry
Conjugate/TagVio Bright FITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
TargetCD101
IsotypeIgG1
CloneBB27
Hostmouse
Antibody TypePrimary antibodies
NCBI Full Gene NameCD101 molecule
NCBI Gene AliasesEWI-101, IGSF2, V7
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 productionEuropean journal of immunologyNovember 1, 2000Bouloc A, Bagot M, Delaire S, Bensussan A, Boumsell L.

(2) V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocationJournal of immunology (Baltimore, Md. : 1950)July 1, 1998Soares LR, Tsavaler L, Rivas A, Engleman EG.

(3) CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activationTissue antigensNovember 1, 1997Bagot M, Martinel I, Charue D, Weill F, Boulland ML, Wechsler J, Freeman GJ, Bensussan A, Boumsell L.

(4) V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studiesJournal of immunology (Baltimore, Md. : 1950)May 1, 1995Rivas A, Ruegg CL, Zeitung J, Laus R, Warnke R, Benike C, Engleman EG.

Be the First to Write a Review!